These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8076633)

  • 1. Purification and characterization of active and stable recombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coli.
    Sancho E; Tonge DW; Hockney RC; Booth NA
    Eur J Biochem; 1994 Aug; 224(1):125-34. PubMed ID: 8076633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.
    Lee HJ; Im H
    Protein Expr Purif; 2003 Sep; 31(1):99-107. PubMed ID: 12963346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.
    Lawrence DA; Olson ST; Palaniappan S; Ginsburg D
    Biochemistry; 1994 Mar; 33(12):3643-8. PubMed ID: 8142362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.
    Mikus P; Urano T; Liljeström P; Ny T
    Eur J Biochem; 1993 Dec; 218(3):1071-82. PubMed ID: 7506655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli.
    Seetharam R; Dwivedi AM; Duke JL; Hayman AC; Walton HL; Huckins NR; Kamerkar SM; Corman JI; Woodeshick RW; Wilk RR
    Biochemistry; 1992 Oct; 31(41):9877-82. PubMed ID: 1382596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level expression of active human plasminogen activator inhibitor type 1 (PAI-1) in E. coli.
    Zhou A; Pei Y; Wu H; Dong X; Xu X
    Biochem Mol Biol Int; 1996 May; 39(2):235-42. PubMed ID: 8799449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
    Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
    J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
    Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
    Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
    Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
    Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
    J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerization of plasminogen activator inhibitor-1.
    Zhou A; Faint R; Charlton P; Dafforn TR; Carrell RW; Lomas DA
    J Biol Chem; 2001 Mar; 276(12):9115-22. PubMed ID: 11102455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms.
    Sancho E; Declerck PJ; Price NC; Kelly SM; Booth NA
    Biochemistry; 1995 Jan; 34(3):1064-9. PubMed ID: 7827021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetically controlled folding of the serpin plasminogen activator inhibitor 1.
    Wang Z; Mottonen J; Goldsmith EJ
    Biochemistry; 1996 Dec; 35(51):16443-8. PubMed ID: 8987976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renaturation, purification, and characterization of human plasminogen activator inhibitor type 2 (PAI-2) accumulated at high level in Escherichia coli.
    Zhou A; Jiang X; Dou F; Zhu D; Xu X
    J Biochem; 1997 May; 121(5):930-4. PubMed ID: 9192735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type 1 (PAI-1) expressed in Chinese hamster ovary cells: comparison with native human PAI-1.
    Strömqvist M; Andersson JO; Boström S; Deinum J; Ehnebom J; Enquist K; Johansson T; Hansson L
    Protein Expr Purif; 1994 Aug; 5(4):309-16. PubMed ID: 7950376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acid stabilization of plasminogen activator inhibitor-1 depends on protonation of a single group that affects loop insertion into beta-sheet A.
    Kvassman JO; Lawrence DA; Shore JD
    J Biol Chem; 1995 Nov; 270(46):27942-7. PubMed ID: 7499270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate.
    Urano T; Strandberg L; Johansson LB; Ny T
    Eur J Biochem; 1992 Nov; 209(3):985-92. PubMed ID: 1425706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
    Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.